Nifty
:
26129.60
Sensex
:
85220.60
190.75 (0.74%)
545.52 (0.64%)
Nifty
Sensex
:
:
26129.60
85220.60
190.75 (0.74%)
545.52 (0.64%)

Panacea Biotec Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :
47/99

BSE: 531349 | NSE: PANACEABIO

NSE BSE
376.30
31-Dec-2025
  • Open
  • High
  • Low
  • Previous Close
  •  388
  •  388
  •  372.65
  •  386.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  487668
  •  185020760.65
  •  581.9
  •  281.1

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,304.56
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,245.85
  • N/A
  • 2.79

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.48%
  • 1.69%
  • 17.69%
  • FII
  • DII
  • Others
  • 1.06%
  • 0.00%
  • 7.08%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.54
  • -2.20
  • 6.72

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -23.35

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -7.63
  • -43.57
  • -36.85

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.39
  • 4.03
  • 1.90

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -241.09
  • -389.89
  • -626.82

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Net Sales
141.13
147.35
-4.22%
166.70
115.72
44.05%
132.53
136.46
-2.88%
163.49
150.50
8.63%
Expenses
158.92
140.35
13.23%
167.88
129.71
29.43%
159.41
142.50
11.87%
155.53
150.65
3.24%
EBITDA
-17.79
7.00
-
-1.18
-13.99
-
-26.88
-6.04
-
7.96
-0.15
-
EBIDTM
-12.61%
4.75%
-0.71%
-12.09%
-20.28%
-4.43%
4.87%
-0.10%
Other Income
6.40
4.65
37.63%
5.67
3.80
49.21%
8.59
10.81
-20.54%
3.62
5.68
-36.27%
Interest
2.14
0.98
118.37%
0.86
0.87
-1.15%
1.04
0.82
26.83%
0.99
0.85
16.47%
Depreciation
8.34
8.68
-3.92%
8.39
8.73
-3.89%
8.42
8.81
-4.43%
8.98
9.11
-1.43%
PBT
-19.17
4.76
-
6.56
-17.05
-
-0.04
-2.12
-
4.38
-1.65
-
Tax
-5.16
0.05
-
2.60
-1.17
-
1.95
-0.13
-
-0.06
0.55
-
PAT
-14.01
4.71
-
3.96
-15.88
-
-1.99
-1.99
-
4.44
-2.20
-
PATM
-9.93%
3.20%
2.38%
-13.72%
-1.50%
-1.46%
2.72%
-1.46%
EPS
-2.27
0.78
-
0.66
-2.58
-
-0.31
-0.23
-
0.74
-0.37
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
603.85
559.09
559.17
459.95
661.23
624.80
544.06
456.70
592.79
544.01
653.08
Net Sales Growth
9.78%
-0.01%
21.57%
-30.44%
5.83%
14.84%
19.13%
-22.96%
8.97%
-16.70%
 
Cost Of Goods Sold
250.79
199.54
230.12
252.66
262.20
204.63
156.79
172.24
187.25
149.52
215.81
Gross Profit
353.06
359.56
329.04
207.29
399.03
420.17
387.27
284.45
405.55
394.50
437.27
GP Margin
58.47%
64.31%
58.84%
45.07%
60.35%
67.25%
71.18%
62.28%
68.41%
72.52%
66.96%
Total Expenditure
641.74
585.01
579.23
557.90
674.43
548.18
518.57
589.83
508.26
496.89
541.37
Power & Fuel Cost
-
38.93
35.95
31.95
37.82
30.94
29.74
34.55
33.52
30.55
25.15
% Of Sales
-
6.96%
6.43%
6.95%
5.72%
4.95%
5.47%
7.57%
5.65%
5.62%
3.85%
Employee Cost
-
173.05
149.57
126.48
182.97
156.17
144.42
147.08
151.59
148.12
142.02
% Of Sales
-
30.95%
26.75%
27.50%
27.67%
25.00%
26.54%
32.20%
25.57%
27.23%
21.75%
Manufacturing Exp.
-
64.83
68.25
47.24
78.70
43.22
33.38
44.31
40.05
41.88
39.47
% Of Sales
-
11.60%
12.21%
10.27%
11.90%
6.92%
6.14%
9.70%
6.76%
7.70%
6.04%
General & Admin Exp.
-
35.75
31.38
43.77
53.79
47.48
54.20
71.07
40.39
52.98
39.41
% Of Sales
-
6.39%
5.61%
9.52%
8.13%
7.60%
9.96%
15.56%
6.81%
9.74%
6.03%
Selling & Distn. Exp.
-
36.94
28.52
42.70
48.08
51.18
42.81
31.27
36.98
37.70
44.20
% Of Sales
-
6.61%
5.10%
9.28%
7.27%
8.19%
7.87%
6.85%
6.24%
6.93%
6.77%
Miscellaneous Exp.
-
35.97
35.43
13.10
10.86
14.56
57.24
89.31
18.48
36.14
44.20
% Of Sales
-
6.43%
6.34%
2.85%
1.64%
2.33%
10.52%
19.56%
3.12%
6.64%
5.41%
EBITDA
-37.89
-25.92
-20.06
-97.95
-13.20
76.62
25.49
-133.13
84.53
47.12
111.71
EBITDA Margin
-6.27%
-4.64%
-3.59%
-21.30%
-2.00%
12.26%
4.69%
-29.15%
14.26%
8.66%
17.11%
Other Income
24.28
20.66
25.80
51.66
10.97
9.98
30.35
5.06
8.23
46.59
20.35
Interest
5.03
3.88
3.58
4.44
180.84
185.34
173.98
104.83
100.58
100.93
127.33
Depreciation
34.13
34.81
36.71
39.12
43.78
45.59
44.13
55.03
58.53
67.95
73.32
PBT
-8.27
-43.94
-34.56
-89.86
-226.85
-144.32
-162.28
-287.93
-66.35
-75.17
-68.59
Tax
-0.67
0.77
2.98
46.55
371.02
1.96
16.95
8.56
9.86
-10.98
1.92
Tax Rate
8.10%
-9.69%
202.72%
363.67%
25.60%
-1.36%
-9.54%
18.58%
-14.86%
16.28%
-10.14%
PAT
-7.60
-8.37
-1.17
-33.23
1,078.31
-146.24
-194.60
37.58
-74.18
-54.75
-18.51
PAT before Minority Interest
-7.24
-8.72
-1.50
-33.74
1,078.33
-146.20
-194.63
37.52
-76.20
-56.47
-20.85
Minority Interest
0.36
0.35
0.33
0.51
-0.02
-0.04
0.03
0.06
2.02
1.72
2.34
PAT Margin
-1.26%
-1.50%
-0.21%
-7.22%
163.08%
-23.41%
-35.77%
8.23%
-12.51%
-10.06%
-2.83%
PAT Growth
0.00%
-
-
-
-
-
-
-
-
-
 
EPS
-1.24
-1.37
-0.19
-5.42
175.91
-23.86
-31.75
6.13
-12.10
-8.93
-3.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
834.79
842.05
843.60
876.64
-228.69
198.79
350.40
308.68
355.68
448.61
Share Capital
6.13
6.13
6.13
6.13
6.13
6.13
6.13
6.13
6.13
22.43
Total Reserves
828.66
835.92
837.48
870.51
-234.82
160.66
344.27
302.55
349.55
426.18
Non-Current Liabilities
103.62
265.09
270.70
85.10
959.99
740.66
70.08
591.13
718.78
1,100.11
Secured Loans
0.00
0.00
0.18
0.24
675.05
583.55
8.90
560.45
704.57
866.08
Unsecured Loans
22.21
20.99
19.98
33.87
60.03
29.58
37.22
10.26
9.49
1.00
Long Term Provisions
46.82
199.27
198.02
29.16
30.65
42.74
39.78
26.54
18.36
184.42
Current Liabilities
366.99
308.98
329.73
773.77
449.09
622.14
938.26
695.52
689.13
474.80
Trade Payables
225.76
145.56
177.32
234.72
246.66
198.85
269.71
277.19
248.60
187.87
Other Current Liabilities
104.87
127.60
115.71
503.01
189.06
242.12
585.25
242.00
237.52
93.60
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
3.57
69.39
164.88
190.71
191.82
Short Term Provisions
36.37
35.82
36.70
36.03
13.37
177.60
13.92
11.44
12.30
1.51
Total Liabilities
1,301.23
1,412.30
1,440.54
1,732.53
1,177.39
1,558.55
1,355.73
1,592.38
1,774.13
2,024.60
Net Block
551.12
569.26
599.95
622.07
608.70
657.39
805.56
948.97
1,001.37
1,071.11
Gross Block
1,327.84
1,311.87
1,330.83
1,313.94
1,266.39
1,282.22
1,392.90
1,605.84
1,600.07
1,620.29
Accumulated Depreciation
776.73
742.62
730.88
691.87
657.69
624.84
587.34
656.87
598.70
549.18
Non Current Assets
756.05
926.83
874.32
744.57
666.41
875.27
847.84
1,027.55
1,070.91
1,475.22
Capital Work in Progress
128.05
101.50
42.32
17.26
34.42
24.01
22.51
39.92
30.41
115.78
Non Current Investment
0.07
0.07
0.07
0.07
0.07
5.58
5.33
5.25
7.01
5.19
Long Term Loans & Adv.
58.01
242.44
228.23
21.46
17.62
187.70
13.33
28.01
22.03
236.71
Other Non Current Assets
3.01
0.97
3.74
83.71
5.61
0.60
1.12
5.39
10.09
1.26
Current Assets
545.18
485.47
562.32
950.55
510.97
683.27
507.89
564.83
703.22
549.38
Current Investments
3.15
40.36
13.42
5.00
0.00
0.00
0.00
2.03
0.27
3.52
Inventories
213.67
177.94
202.09
212.72
174.14
147.69
81.43
334.21
315.55
305.24
Sundry Debtors
72.56
57.42
60.09
81.66
84.68
68.52
88.73
136.01
142.17
141.67
Cash & Bank
106.97
122.00
225.99
583.28
135.79
89.75
23.48
23.24
14.13
22.93
Other Current Assets
148.83
11.97
8.41
8.75
116.36
377.31
314.25
69.36
231.09
76.02
Short Term Loans & Adv.
132.89
75.77
52.31
59.15
63.72
41.62
41.02
59.30
56.21
66.76
Net Current Assets
178.19
176.49
232.59
176.79
61.88
61.13
-430.38
-130.69
14.08
74.58
Total Assets
1,301.23
1,412.30
1,436.64
1,695.12
1,177.38
1,558.54
1,355.73
1,592.38
1,774.13
2,024.60

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-27.37
3.47
-422.45
-108.45
106.76
-30.47
104.80
118.02
130.67
90.69
PBT
-7.95
1.48
12.81
1,449.36
-145.03
-177.34
46.23
-66.14
-67.18
-18.93
Adjustment
-9.87
-5.74
-95.87
-1,454.97
230.88
253.04
-70.58
166.62
149.57
148.75
Changes in Working Capital
-8.58
10.23
-336.91
300.86
21.91
-97.50
127.32
21.45
43.32
-58.26
Cash after chg. in Working capital
-26.40
5.97
-419.98
295.25
107.76
-21.80
102.97
121.93
125.71
71.56
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.97
-2.51
-2.48
-403.70
-1.00
-8.67
1.83
-3.91
4.96
19.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
64.98
6.66
430.33
1,282.57
-47.68
-34.76
-5.27
55.29
-25.83
16.44
Net Fixed Assets
-32.23
-43.47
-13.92
-26.71
28.01
223.59
488.74
-15.06
-27.48
11.93
Net Investments
0.00
0.00
0.00
0.00
54.26
-51.99
342.34
0.00
49.78
0.00
Others
97.21
50.13
444.25
1,309.28
-129.95
-206.36
-836.35
70.35
-48.13
4.51
Cash from Financing Activity
-2.66
-2.81
-18.37
-1,175.84
-47.11
90.74
-101.14
-164.35
-106.96
-117.38
Net Cash Inflow / Outflow
34.95
7.32
-10.49
-1.72
11.97
25.51
-1.61
8.97
-2.13
-10.25
Opening Cash & Equivalents
47.17
39.85
50.35
52.08
40.22
14.47
16.44
7.47
9.59
19.97
Closing Cash & Equivalent
82.13
47.17
39.85
50.35
52.08
40.22
14.47
16.44
7.47
9.73

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
136.29
137.48
137.73
143.12
-37.34
27.23
57.21
50.40
58.07
-4.43
ROA
-0.64%
-0.11%
-2.12%
74.05%
-10.69%
-13.36%
2.55%
-4.53%
-2.97%
-1.01%
ROE
-1.04%
-0.18%
-3.92%
332.85%
0.00%
-75.26%
11.39%
-22.94%
-34.38%
0.00%
ROCE
-0.47%
0.59%
1.94%
217.12%
5.36%
-0.38%
13.44%
2.63%
2.76%
9.93%
Fixed Asset Turnover
0.43
0.43
0.36
0.54
0.51
0.41
0.30
0.37
0.35
0.40
Receivable days
42.20
37.70
54.62
43.66
42.68
52.75
89.81
85.16
92.84
67.10
Inventory Days
127.15
121.93
159.84
101.55
89.66
76.86
166.09
198.91
203.06
171.89
Payable days
339.61
256.06
297.63
335.05
397.33
178.20
213.56
186.55
163.89
130.73
Cash Conversion Cycle
-170.26
-96.42
-83.17
-189.84
-264.98
-48.60
42.34
97.52
132.00
108.26
Total Debt/Equity
0.03
0.02
0.02
0.04
-3.58
4.45
1.85
3.05
2.79
-100.22
Interest Cover
-1.05
1.41
3.89
9.01
0.22
-0.02
1.44
0.34
0.33
0.85

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Panacea Biotec gets Award notification from Pan American Health Organization
    12th Nov 2025, 11:08 AM

    The total award to the company is for supply of Easyfive-TT Vaccine aggregating around $4.75 million during Calendar Year 2026 and 2027

    Read More
  • Panacea Biotec gets LoA worth Rs 127.2 crore
    9th Oct 2025, 15:58 PM

    The company will supply the vaccine in several tranches over a period of 90-480 days from the date of issuance of LoA

    Read More
  • Panacea Biotec gets LoA worth Rs 315 crore
    3rd Oct 2025, 15:19 PM

    The LoA is for a long-term agreement for supply of bivalent oral polio vaccine (bOPV) to UNICEF

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.